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Palmitoylation of the luteinizing hormone/human chorionic
gonadotropin receptor regulates receptor interaction with the
arrestin-mediated internalization pathway
Utpal M. Munshi, Helle Peegel and K. M. J. Menon
Departments of Biological Chemistry and Obstetrics/Gynecology, University of Michigan Medical School, Ann Arbor, MI, USA
The luteinizing hormone/human chorionic gonadotropin
receptor (LH/hCGR) undergoes palmitoylation at cysteine
residues 621 and 622 located in the carboxyl terminal tail of
the receptor. This study examined the biological function of
palmitoylation with respect to its effect on receptor
internalization. Coexpression of wild-type (WT) or C621/
622G mutant receptors with arrestin-2 increased receptor
internalization in 293T cells. Furthermore, measurements
of rate enhancement upon overexpression of arrestin
indicate that the palmitoylation deficient mutant receptor
is more prone to utilizing the arrestin mediated internaliza-
tion pathway than the WT receptor. Coexpression of
G-protein-coupled receptor kinase 4 (GRK4) with wild
type receptor resulted in an increase in internalization,
while coexpression with the mutant receptor did not result
in further enhancement of internalization. Additionally,
293T cells expressing mutant receptor were responsive to
hCG with respect to production of inositol phosphates.
Taken together, these results suggest that the palmitoylation
state of the receptor governs internalization by regulating
the accessibility of the receptor to the arrestin-mediated
internalization pathway.
Keywords: arrestin; GRK; internalization; LH/hCGR;
palmitoylation.
Luteinizing hormone (LH) and its placental counterpart,
human chorionic gonadotropin (hCG), bind to their
receptor (LH/hCGR) in gonadal tissues, resulting in the
increased production of cAMP and subsequent steroido-
genesis [1]. LH/hCGR is a member of the G-protein-
coupled receptor (GPCR) family. These receptors
contain an N-terminal extracellular domain, seven trans-
membrane domains, and a C-terminal cytoplasmic tail
[2,3].
LH/hCGR is palmitoylated at cysteine residues 621
and 622 [4]. While palmitoylation of GPCRs is well
conserved, its biological role varies from one member
of the family to another [5±8]. For example,
palmitoylation deficient mutants of the b2 adrenergic
receptor (b2AR) exhibit a decreased ability to activate
adenylate cyclase [5,9] while corresponding mutants of the
LH/hCGR retain the ability to mediate activation of this
pathway [4,10]. Furthermore, palmitoylation has been
shown to produce varying effects on receptor turnover
[4,11,12].
Our previous studies showed that mutagenesis of
palmitoylation sites has no effect on the ability to
stimulate cyclic AMP production, but enhanced the rate
of ligand-induced receptor internalization [4,10]. The
present study examines the mechanism by which palmi-
toylation of the receptor affects internalization of the
ligand±receptor complex. Specifically, we examined the
interaction of the WT and palmitoylation deficient
mutant receptor with arrestin, a component of the cell's
endocytotic machinery [13±16]. Additionally, the role of
palmitoylation on the receptor's ability to undergo
G-protein coupled receptor kinase (GRK) stimulated
internalization was examined, as GRKs are generally
believed to play a role in hormone-induced phosphorylation
of GPCRs and subsequent internalization [13±16]. The role
of palmitoylation on the receptor's ability to undergo phos-
phorylation was also examined, as arrestin is believed to
preferentially bind the phosphorylated form of GPCRs
[13,14].
In addition to stimulation of cyclic AMP production,
LH is also able to stimulate phosphotidylinositol
hydrolysis [17,18]. Activation of downstream kinases
stimulated by this pathway could lead to receptor phos-
phorylation [19±21]. To further delineate the role of
palmitoylation in receptor function, the activation of the
phosphotidylinositol hydrolysis signaling pathway in
response to hCG was measured in cells expressing WT or
mutant receptor.
The results presented in this study show that a lack of
palmitate at cysteine residues 621 and 622 renders the
receptor more susceptible to arrestin-mediated inter-
nalization. Based on these results it is proposed that
depalmitoylation might be an integral part of the
mechanism by which the LH/hCG receptor is internalized.
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Materials
Human chorionic gonadotropin (CR-127) was a gift from
the Center for Population Research, NICHD, National
Institutes of Health. Na125I was purchased from ICN.
Human embryonic kidney cells (293T cells) expressing the
large T antigen were a gift from G. P. Nolan, Stanford
University. 293 cells were purchased from American Tissue
Culture Collection. hCG for nonspecific binding was
purchased from Sigma. All cell culture media was
purchased from Gibco BRL. Fura-2 AM was purchased
from Molecular Probes. myo[3H] inositol, the ECL detec-
tion system, and secondary antibody to anti-GRK4 were
purchased from Amersham Pharmacia. LiCl was purchased
from Mallinckrodt Laboratories. AG 1-X8 formate resin
and nitrocellulose membrane were purchased from Bio-Rad
Laboratories. cDNAs for arrestin 2, 3, and (319±418)
arrestin-2 were kindly provided by J. L. Benovic, Thomas
Jefferson University. cDNAs for GRKs 2, 4 and 6 were
kindly provided as a gift by R. Lefkowitz, Duke University.
Primary antibody to arrestin-2 and GRK4, as well as
secondary antibody to antiarrestin-2 were purchased from
Santa Cruz Biotechnology, Inc. pCMV4 plasmid was a gift
from D. Russell, University of Texas Southern Medical
Center. All reagents used for molecular and cell biology
were purchased in a suitably purified form. Mutant receptor
cDNA was prepared as described previously [4,10].
Cell culture and transfection
Experiments were performed as described previously using
293 or 293T cells [4]. 293T cells were grown in DMEM
containing 4500 mg´L21 glucose, 50 mg´mL21 gentamy-
cin, 9 U´mL21 nystatin, 10 mm Hepes, and 10% fetal
bovine serum at 37 8C in a humidified atmosphere
containing 5% CO2. Cells in exponential growth were
plated 5±9 h before transfection at cell densities of
5±6  106 cells per 100 mm plate for inositol phosphate
studies and 2±3  106 cells per 100-mm plate for
internalization studies. 293T cells were transiently trans-
fected using the calcium phosphate coprecipitation method.
Stable transfections were performed in a similar manner to
transient transfections, utilizing (geneticin) G418 for
selection.
125I-Labelled hCG binding assay
All 125I-labelled hCG binding assays were performed as
described previously [4] using a saturating concentration of
125I-labelled hCG. Briefly, cells were incubated with a
saturating concentration (100 or 120 ng´mL21) of hCG at
4 8C or 37 8C for 30 min with or without a 1000-fold
excess of cold hCG to determine nonspecific binding. The
cells were then washed twice at 4 8C with Waymouth's
media. The radioactivity remaining with the cell pellet was
then counted in a Gamma Trac 1290 g-counter (Tm
Analytic). Specific binding was determined by subtracting
nonspecific binding from total binding.
Receptor-mediated 125I-hCG internalization assay
The assays were performed as previously described [4,22]
with slight modification. Transiently transfected 293T cells
(2±3  106) were harvested with NaCl/Pi-EDTA, washed,
and resuspended in 3±8 mL of Waymouth's 752/1 medium
as described in [22], the cell suspensions (0.2 mL)
transferred into 12  75 mm tubes, and incubated with a
100-ng´mL21 saturating concentration of 125I-labelled hCG
at 37 8C for the time periods specified. Cells were
incubated in the presence of a 1000-fold excess of
unlabeled hCG to measure nonspecific binding. The
reaction was stopped by the addition of 1.5 mL of
Waymouth MB752/1 (4 8C) medium. After vortexing, the
tubes were centrifuged at 4 8C at 1000 g for 5 min. The
supernatant was aspirated and the cells washed again.
Following the second wash, the cells were incubated twice
at 4 8C with 0.5 mL acid buffer (150 mm NaCl, 50 mm
glycine, pH 3.0) for 5 min to remove the surface bound
125I-labelled hCG. Previous studies have shown that greater
than 90% of the surface bound hormone is removed by this
procedure [4]. After each incubation, the cells were
centrifuged at 4 8C at 2000 g for 5 min. The [125I] in the
pellets and acid washes was counted in a Gamma Trac
1290 g counter (Tm Analytic). The radioactivity associated
with the pellet represents the internalized receptor bound
ligand, while radioactivity released by acid wash represents
surface bound ligand.
Determination of the internalization rate constant
The first order rate constant of internalization was
calculated as described previously [22]; the extent of
internalization at 37 8C of 125I-labelled hCG was measured
after 0±30 min of 125I-labelled hCG exposure. The rate
constant was calculated from the equation kt  2.3 log
(surface bound 1 internalized/surface bound), where k is
the first-order rate constant (min21), and t  time (min)
[22].
Western blot analysis
Firstly, 2.4±2.5  106 293T cells were plated and transi-
ently transfected in a 100 mm tissue culture dish as
described above. Approximately 60 h after transfection,
the cells were harvested in NaCl/Pi-EDTA and subse-
quently lysed in NaCl/Pi 1% Tx-100. After allowing lysis to
occur for 20 min on ice, cell lysate was centrifuged for
30 min at approximately 8 8C at 100 000 g. An aliquot of
the supernatant was subsequently run on an SDS/PAGE gel
under denaturing and reducing conditions. After separation
on the gel, proteins were transferred to a nitrocellulose
membrane. Antibody incubations were carried out as per
the manufacturer's instructions, with a 1 : 500 dilution of
goat anti-(arrestin-2) Ig and rabbit anti-GRK4 Ig, and a
1 : 2500 and 1 : 5000 dilution of horse radish peroxidase
linked anti-goat and anti-rabbit Ig, respectively. Protein
detection was performed using the ECL detection system
(Amersham Pharmacia).
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[32P] Labeling of transfected cells used for receptor
purification
Approximately 60 h after transfection of 2±3  106 293T
cells, the DMEM medium was removed and replaced with
Pi-free medium containing 100 mCi´mL
21 of [32P]ortho-
phosphate. The cells were then incubated at 37 8C for 3 h;
500 nm 4b-phorbol 12-myristate 13-acetate (PMA) was
then added to the experimental plates and incubation
extended for another hour.
Purification of LH/hCG receptor using affi-gel
chromatography
LH/hCG receptor was purified as described previously by
hCG affi-gel chromatography [4]. After incubation with
[32P]orthophosphate, cultures were placed on ice and
washed with phosphate buffered saline (NaCl/Pi). The
cells were harvested and washed with buffer A (NaCl/Pi)
supplemented with protease inhibitors (5 mm EDTA, 1 mm
phenylmethanesulfonyl fluoride, 1 mm benzamidine, 1 mm
N-ethylmaleamide, 2 mm leupeptin, and 2 mm trans-epox-
ysuccinyl-l-leucylamido-(4-guanidino)butane (E64), and
phosphatase inhibitors (100 nm okadaic acid, 200 nm
microcystin-LR, 100 mm orthovanadate, and 10 mm NaF).
The cell pellets were solubilized with buffer B (0.15 m
NaCl and 20 mm Hepes, pH 7.4) containing 0.5% Nonidet
P-40, 20% glycerol, and the protease and phosphatase
inhibitors present in buffer A. The supernatants were
applied to affi-Gel covalently linked to highly purified
hCG, and the suspension mixed end-over-end at 4 8C for
16 h. The gel was washed several times and the receptor
eluted with sample buffer C (2% SDS, 10% glycerol,
20 mm EGTA, 0.5 mg´mL21 bromphenol blue and
62.5 mm Tris, pH 6.8) containing the protease and
phosphatase inhibitors contained in buffer A.
SDS/PAGE autoradiography
The purified receptor was subjected to SDS/PAGE on a
7.5% acrylamide gel under reducing conditions (0.05 m
dithiothreitol, 5% 2-mercaptoethanol). The gels were then
dried at 80 8C and exposed to Kodak X-Omat AR film for
approximately 17 h.
Ca21 measurements
Assays were performed using a slight modification of the
procedure described by Liao et al. [23]. Stably transfected
293 cells were labeled with 20 mm Fura-2 AM at 37 8C
for 30 min. After three washes with assay buffer (140 mm
NaCl, 5 mm KCl, 1 mm MgCl2, 1.8 mm CaCl2, 10 mm
dextrose, 0.1% BSA, and 15 mm Hepes, pH 7.4), the
cells were resuspended at a concentration of 1 
106 cells´mL21, the cells placed in a SLM 8000 spectro-
photometer (SLM-Aminco) and maintained at a tempera-
ture of 37 8C. Fluorescence was monitored with an
excitation wavelength of 340 nm and an emission wave-
length of 510 nm in the absence and presence of
1 mg´mL21 CR-127 hCG. EDTA was added to a final
concentration of 13 mm prior to hormone exposure.
Inositol phosphate assays
Assays were performed using a slight modification of the
procedure described by Berridge et al. [24]. Briefly,
transiently transfected 293T cells (5  106) were labeled
at 37 8C for 48 h with 75 mCi [3H]myo-inositol. The cells
were then harvested in NaCl/Pi-EDTA (1 mm), and
resuspended in assay buffer (142 mm NaCl, 30 mm
Hepes, 5.6 mm KCl, 3.6 mm NaHCO3, 2.2 mm CaCl2,
1.0 mm MgCl2, 1 mg´mL
21 d-glucose, 15 mm LiCl
adjusted to pH 7.4). The cells were incubated in this buffer
at 37 8C for at least 15 min prior to stimulation with
hormone in a total volume of 0.5 mL per tube. After
exposure of cells to varying concentrations of hormone at
37 8C for 40 min, the cells were immediately placed on ice,
and 0.5 mL of 20% trichloroacetic acid was added. The
cells were then vortexed and placed on ice for an additional
15 min. Following centrifugation at 2000 g, the supernatant
was transferred to new tubes and washed five times with
2 mL of dH2O saturated ether. The pH was adjusted to
. 6.0 using 1 m NaHCO3, and 1.7 mL of H2O was added to
each tube. Subsequently, 0.5 mL of an AG 1-X8 formate
resin slurry was added to each tube. After vortexing, the
samples were placed at 4 8C overnight. The following day,
the samples were vortexed again, the supernatant was
aspirated, and the resin was washed five times with 2.5 mL
of 5 mm myo-inositol. The resin was then washed with
1 mL of an elution buffer (0.1 m formic acid, 1.2 m
ammonium formate), vortexed, and incubated for 10 min
at room temperature, and centrifuged. An aliquot of the
supernatant was examined for [3H]inositol phosphates
using a Beckman liquid scintillation counter.
Fig. 1. Internalized 125I-labelled hCG as a percentage of surface
bound 125I-labelled hCG in transiently transfected 293T cells
expressing WT or C621/622G receptor with, or without, arrestin-2.
293T cells (2.2  106) were transiently transfected as described in
Experimental procedures with 2.0 mg of WT cDNA, or 6.0 mg of
C621/622G cDNA in the presence, or absence, of 6.0 mg of arrestin-2
cDNA. Empty pCMV4 vector was also transfected into cells to
equalize the mass of DNA used in all plates. Approximately 60 h after
transfection, the cells were harvested and the internalization assays
were performed as described in Experimental procedures. Internaliza-
tion was measured after 20 min of exposure to 100 ng´mL21 125I-
labelled hCG at 378C. Data  % internalized 125I-labelled hCG/
surface bound 125I-labelled hCG (%) ^ SEM.
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R E S U L T S
Effect of arrestin-2 on internalization of palmitoylation
deficient mutant receptor
We determined whether the rate of internalization of the
palmitoylation deficient mutant receptor [4,10] is affected
by overexpression with arrestin. To test this, 293T cells
were transiently transfected with WT or mutant receptor
cDNA in the presence, or absence, of a second vector
encoding arrestin-2. Cells were harvested 60 h after
transfection and internalization was measured at 37 8C
after 20 min of exposure to 125I-labelled hCG. The
internalization of WT and C621/622G LH/hCGR increased
upon coexpression with arrestin-2 (Fig. 1), suggesting that
the palmitoylation deficient mutant receptor can be
internalized by an arrestin-mediated pathway.
To further substantiate that the palmitoylation deficient
receptor is internalized via an arrestin-mediated mechan-
ism, 293T cells were transiently transfected with cDNA
encoding WT or mutant receptor and a truncated, dominant
negative form of arrestin-2 (amino-acid residues 319±418)
that retains the ability to bind clathrin, but is unable to bind
the phosphorylated receptor [16]. Internalization of the
C621/622G mutant receptor was inhibited when coex-
pressed with the dominant negative form of arrestin-2 (Fig.
2). A 62.5 ^ 3.5% (SEM of two independent experiments)
decrease in internalization of the mutant receptor was seen
when coexpressed with (319±418) arrestin-2 compared to a
20.5 ^ 4.5% (SEM of two independent experiments)
decrease for the WT control. The inhibition of mutant
receptor internalization by the dominant negative arrestin-2
further shows that the palmitoylation deficient mutant
receptor internalization occurs in large part through an
arrestin-mediated pathway.
To examine more closely the influence of the palmitoy-
lation state of the receptor on interaction with the arrestin-
mediated internalization pathway, the time course of WT or
mutant receptor internalization in the absence or presence
of coexpressed arrestin-2 was examined. Cells (293T) were
transiently transfected with the appropriate cDNAs, har-
vested 60 h later, and the time course of internalization was
determined. The percent internalization of WT and mutant
Fig. 2. Internalized 125I-labelled hCG as a percentage of surface
bound 125I-labelled hCG in transiently transfected 293T cells
expressing WT or C621/622G receptor with or without (319±418)
arrestin-2. 293T cells (2.2  106) were transiently transfected as
described in Experimental procedures with 1.68 mg of WT cDNA, or
4.40 mg of C621/622G cDNA, with, or without, 6.71 mg of (319±418)
arrestin-2 cDNA. Empty pCMV4 vector was also transfected into cells
to equalize the mass of DNA used in all plates. Approximately 60 h
after transfection, the cells were harvested and the internalization
assays performed as described in Experimental procedures. Inter-
nalization was measured after 20 min of exposure to 100 ng´mL21
125I-labelled hCG at 378C. The data shown are the results of one of two
experiments conducted and show internalized 125I-labelled hCG/
surface bound 125I-labelled hCG (%).
Fig. 3. Time course and rate of 125I-labelled hCG internalization in
cells expressing WT or C621/622G receptor with or without
arrestin-2. 293T cells (2.4±2.5  106) were transiently transfected
as described in Experimental procedures with 2.0 mg of WT cDNA, or
6.0 mg of C621/622G cDNA with or without 6.0 mg of arrestin-2
cDNA. Empty pCMV4 vector was also transfected into cells to
equalize the mass of DNA used in all plates. Approximately 60 h after
transfection, cells were harvested and internalization assays performed
as described in Experimental procedures. Internalized 125I-labelled
hCG was measured, as described in Experimental procedures, from 0
to 30 min of exposure to 100 ng´mL21 125I-labelled hCG at 378C and is
expressed as a percentage of surface-bound 125I-labelled hCG in cells
expressing WT or mutant receptor with or without (A) arrestin-2. The
data are representative of four independent experiments ^ SEM. (B)
Western blot showing relative expression of arrestin-2 in cells
transfected with WT or C621/622G receptor cDNA with or without
cDNA expressing arrestin-2 as described for (A) loaded with
approximately 11.5 mg of total protein per lane, except for MT
(mock transfect) lane, where approximately 7.5 mg of total protein was
loaded.
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receptor in the absence or presence of coexpressed
arrestin-2 increased with time (Fig. 3A).
The first order rate constants of internalization were
calculated from the data presented in Fig. 3A and are
summarized in Table 1. The results show that the rate
constants of internalization were higher upon coexpression
of arrestin-2 for both the WT and the mutant receptor.
Interestingly, coexpression of arrestin-2 along with the WT
receptor resulted in a greater rate enhancement compared to
that seen for the mutant receptor. This suggests that a
lack of palmitoylation of the receptor renders it more
susceptible to internalization via endogenous arrestin, such
that overexpression of exogenous arrestin can not stimulate
mutant receptor internalization as much as WT receptor
internalization. LH/hCGR cell surface expression was
measured by incubating cells with 125I-labelled hCG for
30 min at 4 8C. Results indicated comparable cell surface
receptor expression between WT and mutant receptor
expressing cells (data not shown). Furthermore, arrestin-2
overexpression in cells expressing mutant receptor was
slightly lower than in cells expressing WT receptor
(Fig. 3B). Densitometric analysis showed that arrestin-2
overexpression in cells expressing the C621/622G
receptor was approximately 80% of that in cells expressing
the WT receptor (data not shown). However, in both
cases, arrestin-2 was overexpressed at a high level, and
therefore any differences in arrestin-2 overexpression
are unlikely to contribute to the differences in rate
enhancement.
Effect of GRK4 on receptor internalization
As arrestin is known to preferentially bind the phos-
phorylated form of GPCRs [13,14], the time course of WT
and palmitoylation deficient mutant receptor internalization
in the absence, or presence, of coexpressed GRK4, which
can promote agonist induced phosphorylation of the
receptor [19], was examined. The internalization of the
WT and the mutant receptors increased over time when
coexpressed with GRK4 (Fig. 4A). The first order rate
constants of internalization were calculated from the data
presented in Fig. 4A and are summarized in Table 2. While
the rate constant of internalization of the mutant receptor
was not increased by GRK4 coexpression, the rate
enhancement seen for the WT receptor was substantial.
This suggests that a lack of palmitoylation renders the
receptor less susceptible to stimulation of internalization
by exogenous GRKs. LH/hCGR cell surface expression
was measured by incubating cells with 125I-labelled hCG
for 30 min at 4 8C. Results indicated comparable receptor
expression between WT and mutant receptor expressing
cells (data not shown). Furthermore, GRK4 overexpression
was comparable in cells expressing WT or mutant
receptor (Fig. 4B). Densitometric analysis showed that
GRK4 overexpression in cells expressing the C621/622G
mutant receptor was approximately 90% of that in cells
expressing the WT receptor (data not shown). This
difference is too small to account for the large difference
Fig. 4. Time course and rate of 125I-labelled hCG internalization in
cells expressing WT or C621/622G receptor with or without GRK4.
(A) 293T cells (2.4±2.5  106) were transiently transfected as
described in Experimental procedures with 2.0 mg of WT cDNA, or
6.0 mg of C621/622G cDNA in the presence, or absence, of 6.0 mg
GRK4 cDNA. Empty pCMV4 vector was also transfected into cells to
equalize the mass of DNA used in all plates. Approximately 60 h after
transfection, the cells were harvested and internalization assays
performed as described in Experimental procedures. Internalized
125I-labelled hCG was measured as described in Experimental
procedures at 378C after exposure from 0 to 30 min to 100 ng´mL21
125I-labelled hCG and expressed as a percentage of surface-bound
125I-labelled hCG in cells expressing WT or mutant receptor with, or
without, GRK4. The data are representative of five independent
experiments ^ SEM. (B) Western blot showing relative expression of
GRK4 in cells transfected with WT or C621/622G receptor cDNA with
or without cDNA expressing GRK4, as described in (A). Approxi-
mately 7.5 mg of total protein was loaded in the WT and C621/622G
lanes, 5 mg of total protein in the MT (mock transfect) lane, and
approximately 5.5 mg of total protein in the WT 1 GRK4, and C621/
622G1GRK4 lanes, respectively.
Table 1. Effects of arrestin-2 overexpression on WT and mutant




First order rate constant
of 125I-labelled hCG
internalization
 1023 (min21) ^ SEM
Rate
enhancementa
WT 2.01 ^ 0.30 ±
WT 1 arrestin-2 4.49 ^ 0.66 2.2
C621/622G 5.18 ^ 1.23 ±
C621/622G 1 arrestin-2 8.86 ^ 1.52 1.7
a Rate enhancement is the factor by which the rate constant increases
in the presence of coexpressed arrestin-2 for each receptor construct.
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in rate enhancement seen upon GRK4 overexpression between
cells expressing the WT and mutant forms of the receptor.
Effect of PMA on receptor phosphorylation
As the C-terminal portion of the receptor contains
consensus phosphorylation sites for protein kinase C and
protein kinase A [25], the ability of WT and palmitoylation
deficient mutant receptors to undergo phosphorylation in
Fig. 5. PMA-stimulated phosphorylation of WT and palmitoylation
deficient mutant receptors. Sixty hours after transient transfection of
2±3  106 293T with cDNA expressing WT, C621/622G, or C621/
622S cDNA, the cells were labeled with 100 mCi´mL21 [32P]orthopho-
sphate for 3 h as described in Experimental procedures. The cells were
then incubated with, or without, 500 nm PMA for 1 h. The cells were
harvested, and the LH/hCGR purified as described in Experimental
procedures. The purified receptors were subjected to SDS/PAGE under
reducing conditions, and the labeled phosphorylated receptor was
visualized by autoradiography. An equivalent amount of eluate from
the purification procedure was loaded into each lane. Lanes 1 and 2,
C621/622G; lanes 3 and 4, C621/622S; Lanes 5 and 6, WT receptor;
Lanes 1, 3, 5, without PMA; lanes 2,4, and 6 with PMA.
Fig. 6. Calcium release in stably transfected 293 cells expressing
WT or palmitoylation deficient LH/hCG receptor. 293 cells stably
transfected with pCMV4 expressing WT, or C621/622S mutant
receptor were harvested and labeled with Fura 2-AM, as described in
Experimental procedures; 2  106 cells were used per sample. Each
plot shows the fold increase in fluorescence emission over baseline
(fluorescence relative to basal) at 510 nm. [fluorescence relative to
basal vs. time (s) upon addition of 1 mg´mL21 hCG
(arrow)] for cells expressing (A) no receptor, (B) WT receptor or (C)
C621/622S receptor. Data are representative of two independent
experiments.
Table 2. Effects of GRK4 overexpression on WT and mutant




First order rate constant
of 125I-labelled hCG
internalization
 1023 (min21) ^ SEM
Rate
enhancementa
WT 1.79 ^0.22 ±
WT 1 GRK 4 3.50 ^0.22 2.0
C621/622G 4.46 ̂ 0.92 ±
C621/622G 1 GRK 4 4.97 ̂ 0.62 1.1
a Rate enhancement is the factor by which the rate constant increases
in the presence of coexpressed GRK4 for each receptor construct.
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response to PMA or 8-bromo cAMP was examined. The
transfected cells were labeled with [32P]orthophosphate for
3 h. Subsequently, cells expressing WT, C621/622G, or
C621/622S palmitoylation deficient mutant receptors were
treated with 500 nm PMA for 1 h. Controls were incubated
in the absence of PMA. Following the incubation, the cells
were harvested and solubilized. The LH/hCGR was purified
by hCG-affigel chromatography, subjected to SDS/PAGE
under reducing conditions, and the phosphorylated receptor
was visualized by autoradiography, as described in Experi-
mental procedures. The results show (Fig. 5) an increase in
phosphorylation of both the WT and the mutant receptors
upon PMA stimulation. Furthermore, both forms of the
mutant receptor are more susceptible to PMA stimulated
phosphorylation compared to the WT receptor. Densito-
metric analysis showed that PMA stimulated a 3.5-fold
increase in C621/622G phosphorylation, 3.3-fold increase
in C621/622S phosphorylation, and 1.8-fold increase of WT
receptor phosphorylation (data not shown). 8-Bromo cAMP
did not stimulate phosphorylation of the WT receptor to any
appreciable extent (data not shown). These results suggest
that the palmitoylation state may regulate the phos-
phorylation state of the LH/hCG receptor, with the
unpalmitoylated form of the receptor being more
susceptible to phosphorylation.
Effect of hCG on Ca21 release
To further examine the biological role of receptor
palmitoylation, we examined the effect of palmitoylation
on receptor signaling through the phospholipase C pathway.
Specifically, the ability of the palmitoylation deficient
mutant to mediate the hCG-induced production of inositol
phosphates and Ca21 flux from the ER to the cytoplasm
was measured.
The release of Ca21 from the ER into the cytosol upon
hCG binding was detected by an increase in fluorescence
emission at 510 nm in 293 cells stably transfected with WT
or C621/622S mutant receptor cDNA that were loaded with
the fluorescent calcium chelator, Fura-2 AM. The results
presented in Fig. 6A±C show the release of calcium from
the ER into the cytosol in untransfected cells, cells
transfected with WT, or C621/622S cDNA, respectively,
upon addition of 1 mg´mL21 hCG. 293T cells transiently
transfected with C621/622G receptor cDNA also displayed
Ca21 release from the ER into the cytosol upon addition of
1 mg´mL21 hCG (data not shown). These results show that
the palmitoylation deficient mutant receptor retains the
ability to mediate Ca21 release from the ER into the
cytosol.
WT and palmitoylation deficient mutant receptor
mediated activation of inositol phosphates production
To further confirm that the WT and palmitoylation deficient
mutant receptors mediate activation of the phospholipase C
pathway, we measured the production of total inositol
phosphates as a function of hCG concentration in 293T
cells transiently expressing equal numbers of WT or C621/
622S mutant receptor. The results presented in Fig. 7 show
that both the WT and the mutant receptor have the ability to
mediate the activation of inositol phosphate production
upon hCG binding.
D I S C U S S I O N
As a continuation of earlier studies on LH/hCG receptor
palmitoylation [4,10], the present study examined the effect
of overexpression of various components of the cell's
endocytotic machinery on WT and palmitoylation deficient
mutant receptor internalization. Our results show that a lack
of palmitoylation results in a higher rate of internalization,
which is largely arrestin-2 dependent, while the internaliza-
tion of the WT receptor appears to be largely resistant to
dominant negative arrestin-2 inhibition. Additionally,
coexpression of GRK4 increases WT receptor internal-
ization, but has no effect on the internalization of the C621/
622G receptor. Finally, we show that abrogation of
palmitoylation does not eliminate the ability of the
mutant receptor to activate the phospholipase C signaling
pathway.
The basal rate of internalization of the mutant receptor
was higher than the WT, but the WT receptor showed a
greater rate of enhancement of internalization than the
mutant upon overexpression of arrestin-2. This suggests
that the mutant receptor preferentially uses endogenous
arrestin for internalization compared to the WT receptor.
The minimal effect of dominant negative arrestin-2 on WT
receptor internalization may be due to hindrance of the
receptor±arrestin interaction by the two palmitate residues.
This may result in the WT receptor using alternative
pathways of internalization, such as the AP-2 mediated
internalization pathway [26]. Taken together, these data
suggest that a lack of palmitoylation confers on the receptor
a greater ability to undergo arrestin-mediated internaliza-
tion, while palmitoylation interferes with receptor±arrestin
Fig. 7. Increase in total inositol phosphates production in
transiently transfected 293T cells expressing WT or palmitoylation
deficient LH/hCG Receptor. 293T cells (5  106) were transiently
transfected with 3mg of WT cDNA or 12 mg C621/622S mutant cDNA
to give approximately equivalent receptor expression. Twelve hours
later, the cells were labelled with 75 mCi of [3H]myo-inositol. Forty-
eight hours after labeling, the cells were harvested and stimulated with
0 to 5000 ng´mL21 hCG at 378C for 40 min. Total inositol phosphates
were assayed as described in Experimental procedures. The increase in
inositol phosphates production was calculated as the quotient of c.p.m.
of [3H]inositol phosphates produced at a given hCG concentration/
c.p.m. of [3H]inositol phosphates produced at [hCG]  0 for each cell
type.
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interaction and results in the use of alternative internaliza-
tion pathways. As coexpression of arrestin-3 was able to
promote a greater rate enhancement of the mutant receptor
than arrestin-2 (data not shown), it is unlikely that the lower
rate enhancement of the mutant receptor in the presence of
arrestin-2 was due to the limiting nature of other cellular
components required for internalization, such as clathrin
and dynamin.
The lower rate enhancement of the mutant compared to
the WT was also not due to differences in transfection
efficiency (data not shown). It is expected that 293T cells
endogenously express arrestin-2, as coexpression with
(319±418) arrestin-2 inhibited mutant receptor internaliza-
tion. Furthermore, it has been previously shown that
arrestin-2 is expressed in 293 cells and may be ubiquitously
expressed in tissues [27±30]. Along these lines, it was
found that arrestin-2 was overexpressed in cells expressing
the C621/622G mutant receptor at levels comparable to that
seen in cells expressing the WT receptor (Fig. 3B).
Although there is a slight decrease in the level of
overexpression of arrestin-2 in the mutant receptor expres-
sing cells, this decrease is not expected to have an effect on
the rate of internalization. Furthermore, the rate of
internalization of the WT receptor is comparable to the
rate of the C621/622G mutant internalization only when
arrestin-2 is overexpressed with the WT receptor (Table 1).
Thus, the palmitoylation deficient receptor is more
susceptible to interaction with the arrestin-mediated
internalization pathway than the WT receptor.
The GRK family of kinases may play a role in hormone-
induced phosphorylation of GPCRs [13±16]. Overexpres-
sion of GRK4 resulted in an increase in the rate of
internalization of the WT receptor, while there was no
increase for the mutant receptor. Differences in GRK4
overexpression are unlikely to play a role in rate
enhancement (Fig. 4B). Furthermore, the rate of internali-
zation of the WT receptor is comparable to that of the
C621/622G mutant receptor only when GRK4 was over-
expressed in the presence of the WT receptor (Table 2).
This suggests that a lack of palmitoylation facilitates
internalization through promoting receptor phos-
phorylation. As GRKs probably stimulate internalization
through phosphorylation of the C-terminus of the receptor
[13±16,19], it is possible that either the C-terminus is
hyperphosphorylated in the unpalmitoylated mutant, and
consequently GRK4 overexpression has little effect on
internalization, or that a lack of palmitoylation inhibits
GRK4 stimulated internalization through an unknown
mechanism. The hypothesis that the unpalmitoylated
receptor might be hyperphosphorylated is supported by
the data presented in Fig. 5, which show that both
unpalmitoylated forms of the receptor have a greater ability
to undergo PMA-stimulated phosphorylation than the WT
receptor.
Previous studies on the desensitization of the b2AR have
shown that it proceeds through a depalmitoylated,
hyperphosphorylated state [9,28,31±34]. Our finding that
GRK4 overexpression had no effect on mutant receptor
internalization would support the notion that the mutant
receptor might exist in an hyperphosphorylated state
that is more prone to arrestin-mediated internalization. In
summary, the present study suggests that LH/hCG
receptor internalization might proceed through a
depalmitoylated/hyperphosphorylated intermediate during
prolonged exposure to hormone.
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